Pulmonary surfactant and its apoproteins.
AUTOR(ES)
Hawgood, S
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=296681Documentos Relacionados
- The lipoprotein abnormality in Tangier disease: quantitation of A apoproteins.
- Use of human surfactant low molecular weight apoproteins in the reconstitution of surfactant biologic activity.
- Pulmonary surfactant therapy.
- Pulmonary surfactant and its components inhibit secretion of phosphatidylcholine from cultured rat alveolar type II cells.
- Pulmonary surfactant: unanswered questions.